These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36817657)

  • 21. Association of PS gene polymorphism and soluble P-selectin levels in atrial fibrillation thromboembolism population in Xinjiang.
    Bai L; Liu Z; Bakeyi M; Lu W; He P; Yang Y; Wulasihan M
    Biochem Biophys Res Commun; 2014 Sep; 452(3):303-7. PubMed ID: 25089002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-selectin and sICAM-1, biomarkers of endothelial function, predict recurrence of venous thromboembolism.
    Dzikowska-Diduch O; Domienik-Karłowicz J; Górska E; Demkow U; Pruszczyk P; Kostrubiec M
    Thromb Res; 2017 Sep; 157():173-180. PubMed ID: 28780342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of vena cava filters for the management of cancer-related venous thromboembolism: Systematic review and meta-analysis.
    Rojas-Hernandez CM; Zapata-Copete JA; García-Perdomo HA
    Crit Rev Oncol Hematol; 2018 Oct; 130():44-50. PubMed ID: 30196911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Zhang H; Wang X
    Front Med (Lausanne); 2021; 8():693927. PubMed ID: 34262920
    [No Abstract]   [Full Text] [Related]  

  • 25. Venous thromboembolism risk in rheumatoid arthritis patients: a systematic review and updated meta-analysis.
    Hu LJ; Ji B; Fan HX
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7005-7013. PubMed ID: 34859863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.
    Marcucci M; Etxeandia-Ikobaltzeta I; Yang S; Germini F; Gupta S; Agarwal A; Ventresca M; Tang S; Morgano GP; Wang M; Ahmed MM; Neumann I; Izcovich A; Criniti J; Popoff F; Devereaux PJ; Dahm P; Anderson D; Lavikainen LI; Tikkinen KAO; Guyatt GH; Schünemann HJ; Violette PD
    BMJ; 2022 Mar; 376():e066785. PubMed ID: 35264372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis.
    Yang M; Qi J; Tang Y; Wu D; Han Y
    Thromb Res; 2020 Dec; 196():410-413. PubMed ID: 33022489
    [No Abstract]   [Full Text] [Related]  

  • 28. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
    Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
    J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
    Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis.
    Castellucci LA; Cameron C; Le Gal G; Rodger MA; Coyle D; Wells PS; Clifford T; Gandara E; Wells G; Carrier M
    JAMA; 2014 Sep; 312(11):1122-35. PubMed ID: 25226478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis.
    Tang L; Wu YY; Lip GY; Yin P; Hu Y
    Lancet Haematol; 2016 Jan; 3(1):e30-44. PubMed ID: 26765646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis and systematic review of venous thromboembolism prophylaxis in patients undergoing vascular surgery procedures.
    Toth S; Flohr TR; Schubart J; Knehans A; Castello MC; Aziz F
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):869-881.e2. PubMed ID: 32330639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
    Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
    Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The study of soluble P-selectin levels and it's correlation to the severity of coronary artery lesions in coronary heart disease].
    Qu XB; Sun ZQ; Chen MJ; Chen LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Aug; 26(8):617-21. PubMed ID: 16390014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia.
    Turhan H; Erbay AR; Yasar AS; Aksoy Y; Bicer A; Yetkin G; Yetkin E
    Coron Artery Dis; 2005 Feb; 16(1):45-50. PubMed ID: 15654200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis.
    Nalluri SR; Chu D; Keresztes R; Zhu X; Wu S
    JAMA; 2008 Nov; 300(19):2277-85. PubMed ID: 19017914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble P-selectin levels in diabetes mellitus patients with coronary artery disease.
    Aref S; Sakrana M; Hafez AA; Hamdy M
    Hematology; 2005 Jun; 10(3):183-7. PubMed ID: 16019467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab).
    Miroddi M; Sterrantino C; Simmonds M; Caridi L; Calapai G; Phillips RS; Stewart LA
    Int J Cancer; 2016 Nov; 139(10):2370-80. PubMed ID: 27450994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis.
    Kunutsor SK; Seidu S; Khunti K
    Lancet Haematol; 2017 Feb; 4(2):e83-e93. PubMed ID: 28089655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis.
    Castellucci LA; Cameron C; Le Gal G; Rodger MA; Coyle D; Wells PS; Clifford T; Gandara E; Wells G; Carrier M
    BMJ; 2013 Aug; 347():f5133. PubMed ID: 23996149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.